Analyst Price Target is $2.05
▲ +259.02% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for BIOLASE in the last 3 months. The average price target is $2.05, with a high forecast of $3.00 and a low forecast of $1.15. The average price target represents a 259.02% upside from the last price of $0.57.
Current Consensus is
The current consensus among 3 contributing investment analysts is to buy stock in BIOLASE.
BIOLASE, Inc. is a medical device company, which engages in developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.